(R)-3-Amino-4-(3-methyl-phenyl)-butyric acid hydrochloride, identified by its CAS number 269398-82-5, is more than just a chemical compound; it's a critical building block in the intricate world of drug discovery and pharmaceutical synthesis. As a specialized chiral amino acid derivative, its precise molecular structure and high purity are essential for developing new therapeutic agents.

The pharmaceutical industry constantly seeks innovative ways to create more effective and targeted medications. Chiral intermediates like (R)-3-Amino-4-(3-methyl-phenyl)-butyric acid HCl play a pivotal role in this endeavor. The 'R' configuration signifies a specific spatial arrangement of atoms, which is often crucial for a drug molecule's biological activity and efficacy. Incorrect stereochemistry can lead to inactive or even harmful compounds, underscoring the need for absolute certainty in the chemical intermediate's chirality.

For researchers and formulators, identifying a reliable supplier for such critical materials is as important as the compound itself. A reputable manufacturer, especially one based in China, can provide the necessary quality assurance, ensuring that each batch of (R)-3-Amino-4-(3-methyl-phenyl)-butyric acid hydrochloride meets stringent purity requirements (e.g., 97%+). This consistency is vital for reproducible research and seamless scale-up from laboratory benches to production lines.

When inquiring about this product, using search terms like '(R)-3-Amino-4-(3-methyl-phenyl)-butyric acid HCl supplier' or 'pharmaceutical intermediate 269398-82-5 price' will connect you with dedicated vendors. It's advisable to request samples and review Certificates of Analysis to confirm the product's suitability for your specific drug discovery program. Partnering with a responsive manufacturer that offers consistent quality and competitive pricing is key to accelerating your research and development timelines.

In essence, (R)-3-Amino-4-(3-methyl-phenyl)-butyric acid hydrochloride represents a cornerstone for many advanced pharmaceutical developments. Ensuring a stable and high-quality supply chain through trusted manufacturers is a strategic imperative for success in the competitive landscape of drug discovery.